Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 21 June 1991:
Vol. 252. no. 5013, pp. 1700 - 1702
DOI: 10.1126/science.1710828
Prev | Table of Contents | Next

Articles

Science, Vol 252, Issue 5013, 1700-1702
Copyright © 1991 by American Association for the Advancement of Science

articles

Prevention of xenograft rejection by masking donor HLA class I antigens

D Faustman and C Coe

Diabetes Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02129.

Destruction of target cells by cytotoxic T lymphocytes requires the presence of HLA (human lymphocyte antigen) class I antigens on the target cells for adhesion as well as for triggering of the antigen-specific T cell receptor. Rejection of xenogeneic human pancreatic islets and liver was circumvented by masking, before transplantation, donor antigens with F(ab')2 antibody fragments to HLA class I or tissue-specific epitopes. This strategy eliminated the need for recipient immunosuppression and allowed islet xenograft survival beyond 200 days, as demonstrated functionally by C peptide secretion as well as by histology. These in vivo observations are consistent with the importance of donor HLA class I in eliciting graft rejection and have potential applicability to the successful transplantation of other HLA class I-bearing donor tissues.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Biological and biomaterial approaches for improved islet transplantation..
A. S. Narang and R. I. Mahato (2006)
Pharmacol. Rev. 58, 194-243
   Abstract »    Full Text »    PDF »
Human Pancreatic Islet-Derived Progenitor Cell Engraftment in Immunocompetent Mice.
E. J. Abraham, S. Kodama, J. C. Lin, M. Ubeda, D. L. Faustman, and J. F. Habener (2004)
Am. J. Pathol. 164, 817-830
   Abstract »    Full Text »    PDF »
Genome and Hormones: Gender Differences in Physiology: Selected Contribution: Association of gender-related LMP2 inactivation with autoimmune pathogenesis.
T. Hayashi and D. L. Faustman (2001)
J Appl Physiol 91, 2804-2815
   Abstract »    Full Text »    PDF »
Instillation of Allogeneic Lung Antigen-Presenting Cells Deficient in Expression of Major Histocompatibility Complex Class I or II Antigens Have Differential Effects on Local Cellular and Humoral Immunity and on Pathology in Recipient Murine Lungs.
K. M. Heidler, K. Baker, K. Woods, C. Schnizlein-Bick, O. W. Cummings, R. Sidner, B. Foresman, and D. S. Wilkes (2000)
Am. J. Respir. Cell Mol. Biol. 23, 499-505
   Abstract »    Full Text »
Transplantation of embryonic porcine mesencephalic tissue in patients with PD.
J. M. Schumacher, S. A. Ellias, E. P. Palmer, H. S. Kott, J. Dinsmore, P. K. Dempsey, A. J. Fischman, C. Thomas, R. G. Feldman, S. Kassissieh, et al. (2000)
Neurology 54, 1042-1050
   Abstract »    Full Text »    PDF »
Rejection of Cardiac Xenografts by CD4+ or CD8+ T Cells.
Y. Lin, M. P. Soares, K. Sato, K. Takigami, E. Csizmadia, J. Anrather, and F. H. Bach (1999)
J. Immunol. 162, 1206-1214
   Abstract »    Full Text »    PDF »
Induction of Immunologic Tolerance for Transplantation.
A. A. ROSSINI, D. L. GREINER, and J. P. MORDES (1999)
Physiol Rev 79, 99-141
   Abstract »    Full Text »    PDF »
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.
D. Lenschow, Y Zeng, Thistlethwaite JR, A Montag, W Brady, M. Gibson, P. Linsley, and J. Bluestone (1992)
Science 257, 789-792
   Abstract »    PDF »
Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.
J Dhawan, L. Pan, G. Pavlath, M. Travis, A. Lanctot, and H. Blau (1991)
Science 254, 1509-1512
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)